Gregory Piazza,Mary Cushman/LinkedIn
Apr 8, 2026, 14:37
Gregory Piazza: The Rationale and Methods Behind the New AHA/ACC PE Guidelines Clinical Categories
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a post on LinkedIn about a recent article he and Mary Cushman co-authored, adding:
”Published in the Journal of the American College of Cardiology today, a glimpse at the rationale and methods behind the new AHA/ACC PE Guidelines Clinical Categories!
Lots of fun writing this with Dr. Mary Cushman!”
Title: AHA/ACC Acute Pulmonary Embolism Clinical Categories: Perspectives on Development and Application
Authors: Gregory Piazza, Mary Cushman
Read the Full Article on JACC
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 8, 2026, 14:33Ney Carter Borges: Effectiveness and Safety of Andexanet alfa in Life-Threatening Factor Xa Inhibitor-Associated Bleeding
-
Apr 8, 2026, 14:32IFI Foundation Launches A Youth-Led Stroke Awareness Campaign On World Health Day 2026 – OdishaPlus
-
Apr 8, 2026, 14:24Riccardo Mazza: Do Weight, BMI, and Renal Function Independently Predict Acute Events in NVAF Patients on DOACs?
-
Apr 8, 2026, 14:17Chokri Ben Lamine: Anticoagulation Switching Pearls
-
Apr 8, 2026, 14:13Francisco Chacón-Lozsán: Bleeding on Anticoagulation Is Not a Complication, It’s a Turning Point
-
Apr 8, 2026, 07:32Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
-
Apr 8, 2026, 07:14Julian Kyoung-Ryul Chun: Join the Discussion at EHRA 2026
-
Apr 8, 2026, 06:41Stephanie Diez de Sollano: Why Ehlers-Danlos Syndrome Deserves More Attention
-
Apr 7, 2026, 19:17Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT